CliffBio
small molecule

AZMACORT

TRIAMCINOLONE ACETONIDE

Loss of exclusivity—loss of exclusivity
CompanyAbbVie Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameAZMACORT
Active ingredientTRIAMCINOLONE ACETONIDE
Strength0.1MG/INH
Dosage formAEROSOL, METERED
RouteINHALATION
ModalitySmall molecule
FDA approvalApril 1982
Marketing statusDISCN

More from AbbVie Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

AZMACORT patent cliff — loss of exclusivity — | CliffBio